Citations

Clear

4847 citation(s) found for "Yu, Eric".

The Effect of Genetically Guided Mathematical Prediction and the Blood Pressure Response to Pharmacotherapy in Hypertension Patients
Kelley, Eli F. , Olson, Thomas P. , Curry, Timothy B. , Sprissler, Ryan , Snyder, Eric M.

Mayo Clinic

Clinical Medicine Insights: Cardiology | May 3, 2019 | Volume: 13 | Issue: No issue available | Pages: No page available

10.1177/1179546819845883 | PMID 31105432 Get It

Purpose: The purpose of this study was to determine the effectiveness of a simple algorithm to mathematically predict a patients’ response to blood pressure (BP) therapy using functional genes in the 3 major organ systems involved in hypertension. Methods: Eighty-six patients with controlled hypertension completed 1 study visit consisting of a buccal swab collection, measurement of office BP, and a medical chart review for BP history. Genes in the analysis included 14 functional alleles in 11 genes. These genotypes were mathematically summed per organ system to determine whether a patient would likely respond to target therapy. Results: Patients recommended to and taking a diuretic had significantly higher rates of control (<120/<80) than patients recommended but not taking this drug class (0.2 ± 0.1 and 0.03 ± 0.03, respectively). Furthermore, there was a difference between patients genetically recommended and taking an angiotensin receptor blocker (ARB) vs patients recommended but not taking an ARB for the lowest diastolic blood pressure (DBP) and mean arterial pressure (MAP) recorded in the past 2 years (DBP = 66.2 ± 2.9 and 75.3 ± 1.7, MAP = 82.3 ± 2.8 and 89.3 ± 1.5, respectively). In addition, there was a nonsignificant trend for greater reductions in ΔSBP, ΔDBP, and ΔMAP in patients on recommended drug class for beta-blockers, diuretics, and angiotensin II receptor blockers vs patients not on these classes. Conclusion: The present study suggests that simple mathematical weighting of functional genotypes known to control BP may be ineffective in predicting control. This study demonstrates the need for a more complex, weighted, multigene algorithm to more accurately predict BP therapy response.
Volumetric laser endomicroscopy and its application to Barrett's esophagus: results from a 1,000 patient registry
Smith, Michael S. , Konda, Vani J. , Gordon, Stuart R. , DeMeester, Steven R. , Joshi, Vivek , Ganguly, Eric K. , Mashimo, Hiroshi , Jobe, Blair A. , McKinley, Matthew , Wallace, Michael B. , Thakkar, Shyam , Schnoll‐Sussman, Felice , Sharaiha, Reem Z. , Tarnasky, P, Wolfsen, Herbert C. , Hawes, Robert H. , Lipham, John C. , Khara, Harshit S. , Navaneethan, U, Kedia, Prashant , Hasan, Muhammad K. , Sethi, Amrita , Samarasena, Jason , Siddiqui, Uzma D. , Gress, Frank G., Rodríguez, Reynaldo , Lee, C, Gonda, Tamas A. , Waxman, Irving , Hyder, S., Poneros, John M., Sharzehi, Kaveh , Palma, Jack A. Di, Sejpal, Divyesh V., Hagen, J. A., Rothstein, Richard, Sawhney, Mandeep , Malik, Zubair , Chang, Kenneth J. , Fichera, Alessandro , Gaidhane, Monica , Wallace, Michael B , Cash, Brooks D. , Trindade, Arvind J. , Diehl, David L. , Singh, Satish K. , Komatsu, Y, Kahaleh, Michel , Pleskow, Douglas K. , Hyder, S, Oh, Daniel S. , Berzin, Tyler M.

Mayo Clinic

Diseases of the Esophagus | April 30, 2019 | Volume: 32 | Issue: 9 | Pages: No page available

10.1093/dote/doz029 | PMID 31037293 Get It

SUMMARY Volumetric laser endomicroscopy (VLE) uses optical coherence tomography (OCT) for real-time, microscopic cross-sectional imaging. A US-based multi-center registry was constructed to prospectively collect data on patients undergoing upper endoscopy during which a VLE scan was performed. The objective of this registry was to determine usage patterns of VLE in clinical practice and to estimate quantitative and qualitative performance metrics as they are applied to Barrett's esophagus (BE) management. All procedures utilized the NvisionVLE Imaging System (NinePoint Medical, Bedford, MA) which was used by investigators to identify the tissue types present, along with focal areas of concern. Following the VLE procedure, investigators were asked to answer six key questions regarding how VLE impacted each case. Statistical analyses including neoplasia diagnostic yield improvement using VLE was performed. One thousand patients were enrolled across 18 US trial sites from August 2014 through April 2016. In patients with previously diagnosed or suspected BE (894/1000), investigators used VLE and identified areas of concern not seen on white light endoscopy (WLE) in 59% of the procedures. VLE imaging also guided tissue acquisition and treatment in 71% and 54% of procedures, respectively. VLE as an adjunct modality improved the neoplasia diagnostic yield by 55% beyond the standard of care practice. In patients with no prior history of therapy, and without visual findings from other technologies, VLE-guided tissue acquisition increased neoplasia detection over random biopsies by 700%. Registry investigators reported that VLE improved the BE management process when used as an adjunct tissue acquisition and treatment guidance tool. The ability of VLE to image large segments of the esophagus with microscopic cross-sectional detail may provide additional benefits including higher yield biopsies and more efficient tissue acquisition. Clinicaltrials.gov NCT02215291
Genomic Association Analysis Reveals Variants Associated With Blood Pressure Response to Beta‐Blockers in European Americans
Singh, Sonal , Rouby, Nihal El , McDonough, Caitrin W. , Bailey, Kent R. , Boerwinkle, Eric , Chapman, Arlene B. , Gums, John G. , Johnson, Julie A. , Chapman, Arlene B. , Turner, Stephen T. , Gong, Yan , Cooper‐DeHoff, Rhonda M.

Mayo Clinic

Clinical and Translational Science | April 29, 2019 | Volume: 12 | Issue: 5 | Pages: 497-504

10.1111/cts.12643 | PMID 31033190 Get It

European Americans (EA) have a better antihypertensive response to β‐blockers when compared with African Americans, albeit with some variability. We undertook a genomewide association study to elucidate the underlying genetic determinants in EA contributing to this variability in blood pressure (BP) response. A discovery genomewide association study of change in BP post–metoprolol treatment was performed in EA participants (n = 201) from the Pharmacogenomic Evaluation of Antihypertensive Responses‐2 (PEAR‐2) study and tested for replication in the atenolol‐treated EA from the PEAR study (n = 233). Rs294610 in the FGD5, which encodes for FYVE, RhoGEF and PH Domain Containing 5, (expression quantitative trait loci for FGD5 in the small intestine) was significantly associated with increased diastolic BP response to β‐blockers in the PEAR‐2 study (P = 3.41 × 10−6, β = −2.70) and replicated (P = 0.01, β = −1.17) in the PEAR study. Post–meta‐analysis of these studies, an additional single nucleotide polymorphism rs45545233 in the SLC4A1, encoding for Solute Carrier Family 4 Member 1, (expression quantitative trait loci for dual specificity phosphatase 3 in the artery tibial) was identified that was significantly associated with a poor response to β‐blockers (P = 3.43 × 10−6, β = 4.57) and was replicated in the atenolol add‐on cohort (P = 0.007, β = 4.97). We identified variants in FGD5 and SLC4A1, which have been previously cited as candidate genes for hypertension, to be associated with a β‐blocker BP response in EA. Further elucidation is warranted of the underlying mechanisms of these variants and genes by which they influence the BP response to β‐blockers.
Nerve conduction normal values for electrodiagnosis in pediatric patients
Ryan, Conor S. , Conlee, Erin M., Sharma, Rishi , Sorenson, Eric J. , Boon, Andrea J. , Laughlin, Ruple S.

Mayo Clinic

Muscle & Nerve | April 29, 2019 | Volume: 60 | Issue: 2 | Pages: 155-160

10.1002/mus.26499 | PMID 31032944 Get It

ABSTRACT Introduction Existing normal value references for pediatric nerve conduction studies (NCS) are based on limited sample sizes with uncertain reliability, suggesting a need for better normative data. Methods Electronic medical records were reviewed for pediatric patients (0 to <18 years) with normal findings on electromyography and NCS during the period from January 1, 1997 through September 20, 2017. Electrodiagnostic and demographic data were collected. Gaussian and descriptive statistics were used to establish normal values by age group. Results In this study we analyzed 1,918 normal NCS on 1,849 unique pediatric patients. Patients were stratified by age: 0 to <1 month; 1 to <6 months; 6 to <12 months; 12 to <24 months; 2 to <3 years; 3 to <4 years; 4 to <5 years; 5 to <10 years; 10 to <15 years; and 15 to <18 years. Normal reference ranges for amplitude, conduction velocity, and distal latency were established for each age group for 4 motor and 4 sensory nerves. Discussion The large sample size of this study provides reliable reference values for interpreting pediatric NCS. Muscle Nerve 60 : 155–160, 2019
Comparison of Patient‐Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT‐AF Registry
Perino, Alexander C., Shrader, Peter, Turakhia, Mintu P., Ansell, Jack E., Gersh, Bernard J., Fonarow, Gregg C., Go, Alan S., Kaiser, Daniel W., Hylek, Elaine M., Kowey, Peter R., Singer, Daniel E., Thomas, Laine, Steinberg, Benjamin A., Peterson, Eric D., Piccini, Jonathan P., Mahaffey, Kenneth W., Mahaffey, Kenneth W. , Turakhia, Mintu P. , Turakhia, Mintu P , Perino, Alexander C., Shrader, Peter, Ansell, Jack E., Gersh, Bernard J., Fonarow, Gregg C., Go, Alan S., Kaiser, Daniel W., Hylek, Elaine M., Kowey, Peter R., Singer, Daniel E., Thomas, Laine, Steinberg, Benjamin A., Peterson, Eric D., Piccini, Jonathan P.

Mayo Clinic

Journal of the American Heart Association | April 26, 2019 | Volume: 8 | Issue: 9 | Pages: No page available

10.1161/jaha.118.011205 | PMID 31023126 Get It

Background Patient satisfaction with therapy is an important metric of care quality and has been associated with greater medication persistence. We evaluated the association of patient satisfaction with warfarin therapy to other metrics of anticoagulation care quality and clinical outcomes among patients with atrial fibrillation ( AF ). Methods and Results Using data from the ORBIT ‐ AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) registry, patients were identified with AF who were taking warfarin and had completed an Anti‐Clot Treatment Scale ( ACTS ) questionnaire, a validated metric of patient‐reported burden and benefit of oral anticoagulation. Multivariate regressions were used to determine association of ACTS burden and benefit scores with time in therapeutic international normalized ratio range ( TTR ; both ≥75% and ≥60%), warfarin discontinuation, and clinical outcomes (death, stroke, major bleed, and all‐cause hospitalization). Among 1514 patients with AF on warfarin therapy (75±10 years; 42% women; CHA 2 DS 2 ‐ VAS c 3.9±1.7), those most burdened with warfarin therapy were younger and more likely to be women, have paroxysmal AF , and to be treated with antiarrhythmic drugs. After adjustment for covariates, ACTS burden scores were independent of TTR ( TTR ≥75%: odds ratio, 1.01 [95% CI , 0.99–1.03]; TTR ≥60%: odds ratio, 1.01 [95% CI , 0.98–1.05]), warfarin discontinuation (odds ratio, 0.99; 95% CI , 0.97–1.01), or clinical outcomes. ACTS benefit scores were also not associated with TTR , warfarin discontinuation, or clinical outcomes. Conclusions In a large registry of patients with AF taking warfarin, ACTS scores provided independent information beyond other traditional metrics of oral anticoagulation care quality and identified patient groups at high risk for dissatisfaction with warfarin therapy.
A phase I study of vemurafenib and decitabine in metastatic melanoma.
Engelman, Eric Steven, Leon‐Ferre, Roberto A. , Abushahin, Laith , Mott, Sarah C, Phadke, Sneha Deepak , Zakharia, Yousef , Milhem, Mohammed

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 9056-9056

10.1200/jco.2015.33.15_suppl.9056 Get It

Prophylactic doxycycline (doxy) lessens rash from dacomitinib (D) an EGFR inhibitor with no rash or diarrhea improvement from corticosteroids or probiotics.
Keefe, Dorothy Mary Kate, Giri, Nagdeep , Reisman, Arlene, Sbar, Eric, Gernhardt, Diana, Jatoi, Aminah , Lacouture, Mario E. , Sonis, Stephen T. , Wang, Tao

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e19049-e19049

10.1200/jco.2015.33.15_suppl.e19049 Get It

A Human Organotypic Microfluidic Tumor Model Permits Investigation of the Interplay between Patient-Derived Fibroblasts and Breast Cancer Cells
Truong, Danh D. , Kratz, Alexander , Park, Jin G. , Barrientos, Eric S., Saini, Harpinder , Nguyen, Toan, Pockaj, Barbara A. , Mouneimne, Ghassan , Pockaj, Barbara, LaBaer, Joshua , Nikkhah, Mehdi

Mayo Clinic

Cancer Research | April 16, 2019 | Volume: 79 | Issue: 12 | Pages: 3139-3151

10.1158/0008-5472.can-18-2293 | PMID 30992322 Get It

Abstract Tumor–stroma interactions significantly influence cancer cell metastasis and disease progression. These interactions are partly comprised of the cross-talk between tumor and stromal fibroblasts, but the key molecular mechanisms within the cross-talk that govern cancer invasion are still unclear. Here, we adapted our previously developed microfluidic device as a 3D in vitro organotypic model to mechanistically study tumor–stroma interactions by mimicking the spatial organization of the tumor microenvironment on a chip. We cocultured breast cancer and patient-derived fibroblast cells in 3D tumor and stroma regions, respectively, and combined functional assessments, including cancer cell migration, with transcriptome profiling to unveil the molecular influence of tumor–stroma cross-talk on invasion. This led to the observation that cancer-associated fibroblasts (CAF) enhanced invasion in 3D by inducing expression of a novel gene of interest, glycoprotein nonmetastatic B (GPNMB), in breast cancer cells, resulting in increased migration speed. Importantly, knockdown of GPNMB blunted the influence of CAF on enhanced cancer invasion. Overall, these results demonstrate the ability of our model to recapitulate patient-specific tumor microenvironments to investigate the cellular and molecular consequences of tumor–stroma interactions. Significance: An organotypic model of tumor–stroma interactions on a microfluidic chip reveals that CAFs promote invasion by enhancing expression of GPNMB in breast cancer cells.
0966 Navigating the Path to Primary Care Involvement in the Care of Stable Obstructive Sleep Apnea Patients
Moore, Wendy , Harris, Cameron, Kakkar, Gurnoor S, Herold, Daniel L. , Williams, Julie A., Cleveland, Eric J., Mansukhani, Meghna P. , Morgenthaler, Timothy I.

Mayo Clinic

Sleep | April 13, 2019 | Volume: 42 | Issue: Supplement_1 | Pages: A388-A389

10.1093/sleep/zsz067.963 Get It